Drug: progesterone Quarter: 2016Q3
Total Records: 119 Number of Pages: 6
| DRUGNAME | PT | EventCount |
|---|---|---|
| PROGESTERONE. | Cerebral infarction | 7 |
| PROGESTERONE. | Off label use | 5 |
| PROGESTERONE. | Foetal exposure during pregnancy | 4 |
| PROGESTERONE. | Abortion threatened | 3 |
| PROGESTERONE. | Premature baby | 3 |
| PROGESTERONE. | Product use issue | 3 |
| Progesterone Capsules | Abortion spontaneous | 2 |
| Progesterone Capsules | Product use issue | 2 |
| Progesterone Capsules | Vaginal discharge | 2 |
| PROGESTERONE. | Alopecia | 2 |
| PROGESTERONE. | Exposure during breast feeding | 2 |
| PROGESTERONE. | Exposure during pregnancy | 2 |
| PROGESTERONE. | Therapeutic response unexpected | 2 |
| PROGESTERONE. | Uterine haemorrhage | 2 |
| PROGESTERONE. | Ventricular septal defect | 2 |
| PROGESTERONE (SOLVAY PHARMA) | Abortion spontaneous | 1 |
| PROGESTERONE (SOLVAY PHARMA) | Emotional disorder | 1 |
| PROGESTERONE (SOLVAY PHARMA) | Exposure during pregnancy | 1 |
| PROGESTERONE (SOLVAY PHARMA) | Incorrect route of drug administration | 1 |
| PROGESTERONE (SOLVAY PHARMA) | Product use issue | 1 |
Total Records: 119 Number of Pages: 6